MilliporeSigma
  • Home
  • Search Results
  • The stability of DNA intrastrand cross-links of antitumor transplatin derivative containing non-bulky methylamine ligands.

The stability of DNA intrastrand cross-links of antitumor transplatin derivative containing non-bulky methylamine ligands.

Journal of biological inorganic chemistry : JBIC : a publication of the Society of Biological Inorganic Chemistry (2014-07-06)
Michaela Frybortova, Olga Novakova, Viktor Brabec
ABSTRACT

Oligonucleotides modified by clinically ineffective trans-diamminedichloridoplatinum(II) (transplatin) have been shown to be effective modulators of gene expression. This is so because in some nucleotide sequences the 1,3-GNG intrastrand adducts formed by transplatin in double-helical DNA readily rearrange into interstrand cross-links so that they can cross-link the oligonucleotides to their targets. On the other hand, in a number of other sequences these intrastrand adducts are relatively stable, which represents the major difficulty in the clinical use of the antisense transplatin-modified oligonucleotides. Therefore, we examined in this study, the stability of 1,3-GNG intrastrand adducts in double-helical DNA formed by a new antitumor derivative of transplatin, trans-[Pt(CH3NH2)2Cl2], in the sequence contexts in which transplatin formed relatively stable intrastrand cross-links which did not readily rearranged into interstrand cross-links. We have found that 1,3-GNG intrastrand adducts in double-helical DNA formed by trans-[Pt(CH3NH2)2Cl2] even in such sequences readily rearrange into interstrand cross-links. This work also suggests that an enhanced frequency of intrastrand cross-links yielded by trans-[Pt(CH3NH2)2Cl2] is a consequence of the fact that these DNA lesions considerably distort double-helical DNA in far more sequence contexts than parent transplatin. Our results suggest that trans-[Pt(CH3NH2)2Cl2]-modified oligonucleotides represent promising candidates for new agents in antisense or antigene approach.

MATERIALS
Product Number
Brand
Product Description

Sigma-Aldrich
Acrylamide, for molecular biology, ≥99% (HPLC)
Sigma-Aldrich
Dimethyl sulfate, ≥99.5%
Sigma-Aldrich
cis-Diamineplatinum(II) dichloride, ≥99.9% trace metals basis
Sigma-Aldrich
Acrylamide, for Northern and Southern blotting, powder blend
Sigma-Aldrich
Acrylamide, purum, ≥98.0% (GC)
Sigma-Aldrich
Dimethyl sulfate, puriss. p.a., ≥99.0% (GC)
Sigma-Aldrich
Urea solution, BioUltra, ~8 M in H2O
Sigma-Aldrich
Acrylamide, suitable for electrophoresis, ≥99% (HPLC), powder
Sigma-Aldrich
Acrylamide, suitable for electrophoresis, ≥99%
Sigma-Aldrich
Urea solution, 40 % (w/v) in H2O
Sigma-Aldrich
Dimethyl sulfate, ≥99%
Millipore
Urea solution, suitable for microbiology, 40% in H2O
Supelco
Acrylamide, certified reference material, TraceCERT®
USP
Transplatin, United States Pharmacopeia (USP) Reference Standard
Supelco
Acrylamide, analytical standard
Sigma-Aldrich
Urea-12C, 99.9 atom % 12C
Cisplatin impurity A, European Pharmacopoeia (EP) Reference Standard
Sigma-Aldrich
Potassium permanganate, puriss. p.a., ACS reagent, reag. Ph. Eur., ≥99%
Sigma-Aldrich
Potassium permanganate, ≤150 μm particle size, 97%
Sigma-Aldrich
Potassium permanganate, puriss. p.a., ACS reagent, Hg ≤0.000005%, ≥99.0% (RT)
Sigma-Aldrich
Potassium permanganate, ACS reagent, ≥99.0%
Sigma-Aldrich
Potassium permanganate, ACS reagent, ≥99.0%, low in mercury
Sigma-Aldrich
Acrylamide solution, 40%, suitable for electrophoresis, sterile-filtered
Sigma-Aldrich
Urea, ACS reagent, 99.0-100.5%
Sigma-Aldrich
Urea, BioXtra, pH 7.5-9.5 (20 °C, 5 M in H2O)
Sigma-Aldrich
Urea, powder, BioReagent, for molecular biology, suitable for cell culture
Sigma-Aldrich
trans-Platinum(II)diammine dichloride
Sigma-Aldrich
cis-Diammineplatinum(II) dichloride, crystalline
Sigma-Aldrich
Urea, meets USP testing specifications
Sigma-Aldrich
Urea, BioUltra, for molecular biology, ≥99% (T)